Tianjin Chase Sun Pharmaceutical Co. Ltd. | Ownership
Companies that own Tianjin Chase Sun Pharmaceutical Co. Ltd.
Citic Securities Co., Ltd. (Invt Port)
52,520,729
2.27%
977,375
1.75%
09/30/2017
Manulife TEDA Fund Management Co., Ltd.
26,216,898
1.13%
0
0.42%
09/30/2017
China Great Wall Asset Management Co., Ltd. (Invt Mgmt)
18,847,020
0.82%
0
0.48%
09/30/2017
China Southern Asset Management Co., Ltd.
8,533,501
0.37%
-3,999,300
0.04%
12/31/2017
E Fund Management Co., Ltd.
7,670,098
0.33%
-862,500
0.03%
12/31/2017
Fullgoal Fund Management Co., Ltd.
7,104,273
0.31%
-3,513,500
0.04%
12/31/2017
Guotai Asset Management Co., Ltd.
4,348,981
0.19%
-2,905,021
0.04%
12/31/2017
Soochow Asset Management Co., Ltd.
3,596,400
0.16%
3,596,400
0.33%
12/31/2017
The Vanguard Group, Inc.
3,570,505
0.16%
0
0%
07/31/2018
Guotai Junan Allianz Fund Management Co., Ltd.
3,223,500
0.14%
-574,100
0.11%
12/31/2017
| Address |
Quanfa West Road
Tianjin Tianjin 301700
China
|
|
Employees
|
- |
| Website |
http://www.chasesun.cn |
| Updated |
07/08/2019 |
| Tianjin Chase Sun Pharmaceutical Co., Ltd. engages in the investment, manufacturing, and distribution of pharmaceuticals products. Its business includes Chinese herb preparation, Chinese medicinal granule, synthetic drugs, biotech drugs, medical apparatus, and therapies. The company was founded on September 23, 1996 and is headquartered in Tianjin, China. |
